QS Investors’s Medpace MEDP Stock Holding History

QS Investors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$820K	Hold	4,640	–	–	0.01%	546
2021 Q1	$762K	Sell	4,640 -190	-4%	-$29.1K	0.01%	609
2020 Q4	$672K	Hold	4,830	–	–	0.01%	646
2020 Q3	$540K	Sell	4,830 -40,641	-89%	-$4.7M	0.01%	656
2020 Q2	$4.23M	Sell	45,471 -2,400	-5%	-$204K	0.06%	256
2020 Q1	$3.51M	Buy	47,871 +1,900	+4%	+$165K	0.06%	260
2019 Q4	$3.81M	Sell	45,971 -700	-1%	-$54.2K	0.04%	360
2019 Q3	$3.92M	Hold	46,671	–	–	0.04%	342
2019 Q2	$3.05M	Sell	46,671 -849	-2%	-$48.9K	0.03%	430
2019 Q1	$2.8M	Sell	47,520 -317	-0.7%	-$18.9K	0.03%	468
2018 Q4	$2.53M	Buy	47,837 +47,650	+25,481%	+$2.62M	0.03%	445
2018 Q3	$11K	Buy	+187	New	+$10.2K	﹤0.01%	1536

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QS Investors's MEDP Position: Q2 2021 in Review

QS Investors held its Medpace (MEDP) position steady in Q2 2021 at 4,640 shares worth $820K. The position accounts for 0.01% of the portfolio, ranked #546.

QS Investors first reported a position in MEDP in Q3 2018 and has held it in 12 quarters since. The position peaked at $4.23M in Q2 2020. 324 funds tracked by Wall St. Rank hold MEDP as of Q2 2021.

QS Investors held 4,640 shares of Medpace worth $820K as of Q2 2021.
QS Investors left its Medpace share count unchanged in Q2 2021.
Medpace made up 0.01% of QS Investors's portfolio in Q2 2021, its #546 holding.
QS Investors first reported a position in Medpace in Q3 2018 and has held it in 12 quarters since.
QS Investors's Medpace position peaked at $4.23M in Q2 2020.
324 funds tracked by Wall St. Rank held Medpace as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.